Glycyx

Glycyx is at the forefront of cancer treatment by addressing the overlooked issue of opioids reducing immunotherapy effectiveness. As a biotech firm entering Phase 2, we are pioneering a novel therapy to ensure pain management doesn't compromise anti-PD1/PD-L1 treatments. Our goal: to greatly enhanc...